Pages
Inequalities research earns second round of grant funding
https://dchs.nhs.uk/news/inequalities-research-earns-second-round-grant-funding
Quality and safe care champions
https://dchs.nhs.uk/about-us/quality-heart-our-care/quality-always/quality-and-safe-care-champions
Move to Defender AntiVirus
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/move-defender-antivirus
Progress on Belper’s new health centre development – November 2024
https://dchs.nhs.uk/news/progress-belpers-new-health-centre-development-november-2024
Walton Hospital
https://dchs.nhs.uk/our-services-and-locations/our-locations/community-hospitals/walton-hospital
DCHS Clinical IT Systems - User Experience Survey 2022
Are you a user of TPP SystmOne or Inform clinical systems? We’d like to know how it’s working for you and how we might be able to improve it.
Files
Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
PGD Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
A5 - Constipation Pathway (P91)
A5 - Constipation Pathway
Guidelines for Locality Managers and 0-19 Clinicians following notification of a child death (G318)
The aim of this document is to provide guidance for 0-19 clinical staff and Locality Managers following notification by the children’s services administration team of the death of a baby, child, or young person.
Triage Template - Appendix 4 (G323)
Triage Template
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services.pdf
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services
Disclosure Ref 2024134 - Self Declaration July 2021.pdf
Disclosure Ref 2024134 - Self Declaration July 2021
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024
Disclosure Ref 2024191 - Urgent Treatment Centre ophthalmology (eye care) services.pdf
Disclosure Ref 2024191 relating to Urgent Treatment Centre ophthalmology (eye care) services